Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
56,339,028
-
Share change
-
-10,290,830
-
Total reported value
-
$59,142,180
-
Price per share
-
$1.05
-
Number of holders
-
70
-
Value change
-
-$9,988,574
-
Number of buys
-
35
-
Number of sells
-
47
Institutional Holders of ANTARES PHARMA INC - COM (ATRS) as of Q2 2016
As of 30 Jun 2016,
ANTARES PHARMA INC - COM (ATRS) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,339,028 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Broadfin Capital, LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, WILLIAM HARRIS INVESTORS INC, KINGDON CAPITAL MANAGEMENT, L.L.C., MILLENNIUM MANAGEMENT LLC, Pleasant Lake Partners LLC, and Alyeska Investment Group, L.P..
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.